jRCT2031220579已完成不适用
A Phase 1 Study of Apraglutide (Single Dose Study)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 45age old not（—）
- 性别
- All
入选标准
- •The subjects will be individuals who meet all of the following criteria.
- •[1] Healthy Japanese men and women
- •[2] Individuals >=18 to <45 years of age at the time of informed consent
- •[3] Individuals who fully understand the details of the study and who are capable of providing written informed consent
排除标准
- •Individuals meeting any of the following criteria will be excluded from the study.
- •[1] Past history of disease in organsystems considered unsuitable for this study
- •[2] Past history of disease or surgery that could affect pharmacokinetic or pharmacodynamic evaluation
- •[3] Other protocol defined exclusion criteria could apply
结局指标
主要结局
-
Plasma concentration of compound(s)
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
A Phase 1 Study of Apraglutide (Single Dose Study)short bowel syndrome and intestinal failure (SBS-IF)JPRN-jRCT2031220579Kozaki Tomohito36
招募中
2 期
Effect of a single prophylactic dose of pregabalin on pain management and opioid requirement after cerebrocystectomyIRCT20230502058057N1Islamic Azad University80
已完成
不适用
The preemptive effect of a single dose of Pregabalin (Lyrica 300) for post operative pain control after Mandibular surgeryFracture of mandible.Fracture of mandibleIRCT201202281772N10Tabriz University of Medical Science - Research team of anesthesiology60
已完成
4 期
The effects of a single dose preemptive pregabalin on acute and chronic pain after inguinal hernia repair with mesh under spinal anesthesiaacute and chronic pain after inguinal hernia repairAnaesthesiology - Pain managementACTRN12615000435583Ataturk University60
招募中
不适用
Onderzoek naar aflevering van 124-I-F8IL10 in ontstoken gewrichten.Rheumatoid ArthritisNL-OMON28317VU University Medical Center5